AU2013207585A1 - Melatonin agonist treatment - Google Patents

Melatonin agonist treatment

Info

Publication number: AU2013207585A1
Authority: AU; Australia
Prior art keywords: agonist treatment; melatonin agonist; melatonin; treatment; agonist
Prior art date: 2006-05-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2013207585A

Other versions

AU2013207585B2 (en

Inventor

Gunther Birznieks

Deepak Phadke

Mihael H. Polymeropoulos

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Vanda Pharmaceuticals Inc

Original Assignee

Vanda Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-05-22

Filing date

2013-07-17

Publication date

2013-08-08

2007-05-22 Priority claimed from AU2007253701A external-priority patent/AU2007253701A1/en

2013-07-17 Priority to AU2013207585A priority Critical patent/AU2013207585B2/en

2013-07-17 Application filed by Vanda Pharmaceuticals Inc filed Critical Vanda Pharmaceuticals Inc

2013-08-08 Publication of AU2013207585A1 publication Critical patent/AU2013207585A1/en

2016-03-31 Priority to AU2016202001A priority patent/AU2016202001A1/en

2016-04-28 Publication of AU2013207585B2 publication Critical patent/AU2013207585B2/en

2016-04-28 Application granted granted Critical

2016-05-19 Assigned to VANDA PHARMACEUTICALS, INC. reassignment VANDA PHARMACEUTICALS, INC. Amend patent request/document other than specification (104) Assignors: VANDA PHARMACEUTICALS, INC

2018-02-20 Priority to AU2018201219A priority patent/AU2018201219A1/en

2019-10-18 Priority to AU2019250266A priority patent/AU2019250266A1/en

2021-11-24 Priority to AU2021273588A priority patent/AU2021273588B2/en

Status Active legal-status Critical Current

2027-05-22 Anticipated expiration legal-status Critical

Priority Applications (5)

Application Number	Priority Date	Filing Date	Title
AU2013207585A AU2013207585B2 (en)	2006-05-22	2013-07-17	Melatonin agonist treatment
AU2016202001A AU2016202001A1 (en)	2006-05-22	2016-03-31	Melatonin agonist treatment
AU2018201219A AU2018201219A1 (en)	2006-05-22	2018-02-20	Melatonin agonist treatment
AU2019250266A AU2019250266A1 (en)	2006-05-22	2019-10-18	Melatonin agonist treatment
AU2021273588A AU2021273588B2 (en)	2006-05-22	2021-11-24	Melatonin agonist treatment

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US74784706P	2006-05-22	2006-05-22
US60/747,847		2006-05-22
AU2007253701A AU2007253701A1 (en)	2006-05-22	2007-05-22	Melatonin agonist treatment
AU2013207585A AU2013207585B2 (en)	2006-05-22	2013-07-17	Melatonin agonist treatment

Related Parent Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2007253701A Division AU2007253701A1 (en)	2006-05-22	2007-05-22	Melatonin agonist treatment

Related Child Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2016202001A Division AU2016202001A1 (en)	2006-05-22	2016-03-31	Melatonin agonist treatment

Publications (2)

Publication Number	Publication Date
AU2013207585A1 true AU2013207585A1 (en)	2013-08-08
AU2013207585B2 AU2013207585B2 (en)	2016-04-28

Family

ID=38723632

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
AU2007253701A Abandoned AU2007253701A1 (en)	2006-05-22	2007-05-22	Melatonin agonist treatment
AU2013207585A Active AU2013207585B2 (en)	2006-05-22	2013-07-17	Melatonin agonist treatment
AU2021273588A Active AU2021273588B2 (en)	2006-05-22	2021-11-24	Melatonin agonist treatment

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AU2007253701A Abandoned AU2007253701A1 (en)	2006-05-22	2007-05-22	Melatonin agonist treatment

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
AU2021273588A Active AU2021273588B2 (en)	2006-05-22	2021-11-24	Melatonin agonist treatment

Country Status (17)

Country	Link
US (7)	US20090105333A1 (en)
EP (1)	EP2028937B2 (en)
JP (5)	JP2009538332A (en)
KR (2)	KR101571163B1 (en)
AU (3)	AU2007253701A1 (en)
BR (1)	BRPI0712206A2 (en)
CA (2)	CA2666293C (en)
CY (1)	CY1120433T1 (en)
DK (1)	DK2028937T4 (en)
ES (1)	ES2532849T5 (en)
MX (1)	MX2008014841A (en)
NL (1)	NL300795I2 (en)
PL (1)	PL2028937T5 (en)
PT (1)	PT2028937E (en)
RU (1)	RU2488392C2 (en)
WO (1)	WO2007137244A1 (en)
ZA (1)	ZA200809529B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX2008014841A (en) †	2006-05-22	2008-12-05	Vanda Pharmaceuticals Inc	Melatonin agonist treatment.
US11060144B2 (en) *	2007-09-13	2021-07-13	Vanda Pharmaceuticals Inc.	Prediction of sleep parameter and response to sleep-inducing compound based on PER3 VNTR genotype
US20120136050A1 (en) *	2009-07-16	2012-05-31	Vanda Pharmaceuticals Inc.	Use of a melatonin agonist for the treatment of sleep disorders including primary insomnia
US11918557B2 (en)	2012-01-26	2024-03-05	Vanda Pharmaceuticals Inc.	Treatment of circadian rhythm disorders
EP4502609A3 (en) *	2012-01-26	2025-04-09	Vanda Pharmaceuticals Inc.	Determining a circadian rhythm
CN110200958A (en) *	2012-12-18	2019-09-06	万达制药公司	The treatment of circadian rhythm disorder
US11090285B2 (en)	2013-11-12	2021-08-17	Vanda Pharmaceuticals Inc	Treatment of circadian rhythm disorders
US10376487B2 (en)	2013-11-12	2019-08-13	Vanda Pharmaceuticals Inc.	Method of treatment
WO2015117048A1 (en)	2014-01-31	2015-08-06	Vanda Pharmaceuticals Inc.	Treatment of circadian rhythm disorders
HRP20230070T1 (en)	2014-09-02	2023-03-17	Vanda Pharmaceuticals Inc.	Tasimelteon for treating smith-magenis syndrome
US20210059973A1 (en)	2017-08-02	2021-03-04	Vanda Pharmaceuticals Inc.	Treatment of Affective Disorders
WO2019173180A1 (en) *	2018-03-04	2019-09-12	Vanda Pharmaceuticals Inc.	Treatment of disorders with tasimelteon
JP7432884B2 (en) *	2018-03-26	2024-02-19	パナソニックＩｐマネジメント株式会社	Support system, device control system, method of operating the support system, and method of operating the device control system
CN113365618A (en) *	2018-09-12	2021-09-07	万带兰制药公司	Improving sleep or wake-up performance
WO2020168056A1 (en) *	2019-02-13	2020-08-20	Vanda Pharmaceuticals Inc.	Method of improving sleep
WO2021003086A1 (en) *	2019-06-29	2021-01-07	Vanda Pharmaceuticals Inc.	Tasimelteon use in treating sleep aberrations
MX2022006577A (en)	2019-12-13	2022-07-04	Vanda Pharmaceuticals Inc	LIQUID FORMULATIONS OF TASIMELTEON AND METHODS OF ITS USE.

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0126630B1 (en) *	1983-05-18	1987-09-16	Monash University	The use of melatonin for the manufacture of a medicament
US5242941A (en) †	1990-12-04	1993-09-07	State Of Oregon	Methods of treating circadian rhythm disorders
IT1251544B (en) *	1991-05-13	1995-05-17	Gabriele Biella	PHARMACEUTICAL COMPOSITIONS ACTIVE IN THE THERAPY OF SLEEP DISORDERS INCLUDING MELATONIN OR A DERIVATIVE IN ASSOCIATION WITH A BENZODIAZEPINE DERIVATIVE
GB9416884D0 (en) *	1994-08-20	1994-10-12	Danbiosyst Uk	Drug delivery compositions
WO1996027658A1 (en) *	1995-03-06	1996-09-12	Novo Nordisk A/S	Stimulation of meiosis
WO1998025606A1 (en) *	1996-12-10	1998-06-18	Bristol-Myers Squibb Company	Benzodioxole, benzofuran, dihydrobenzofuran, and benzodioxane melatonergic agents
US5776969A (en) *	1997-02-27	1998-07-07	Eli Lilly And Company	Treatment of sleep disorders
US20050137247A1 (en) *	2003-12-22	2005-06-23	The Brigham And Women's Hospital, Inc.	Methods and compositions for treatment of hypertension
WO2005063297A2 (en) *	2003-12-24	2005-07-14	Sepracor Inc.	Melatonin combination therapy for improving sleep quality
KR101187461B1 (en) *	2005-07-29	2012-10-02	반다 파마슈티칼즈, 인코퍼레이티드.	How to improve your awakening
MX2008014841A (en) †	2006-05-22	2008-12-05	Vanda Pharmaceuticals Inc	Melatonin agonist treatment.
US11060144B2 (en) *	2007-09-13	2021-07-13	Vanda Pharmaceuticals Inc.	Prediction of sleep parameter and response to sleep-inducing compound based on PER3 VNTR genotype
EP4502609A3 (en) *	2012-01-26	2025-04-09	Vanda Pharmaceuticals Inc.	Determining a circadian rhythm
US11918557B2 (en) *	2012-01-26	2024-03-05	Vanda Pharmaceuticals Inc.	Treatment of circadian rhythm disorders
CN110200958A (en) *	2012-12-18	2019-09-06	万达制药公司	The treatment of circadian rhythm disorder
US10376487B2 (en) *	2013-11-12	2019-08-13	Vanda Pharmaceuticals Inc.	Method of treatment
US10071977B2 (en) *	2014-02-12	2018-09-11	Vanda Pharmaceuticals Inc.	Highly purifid pharmaceutical grade tasimelteon
HRP20230070T1 (en) *	2014-09-02	2023-03-17	Vanda Pharmaceuticals Inc.	Tasimelteon for treating smith-magenis syndrome
US20170326153A1 (en) †	2014-10-28	2017-11-16	Sandoz Ag	Pharmaceutical Composition Consisting of Ceftaroline Fosamil Acetic Acid Solvate Particles Arginine Particles, Both Having A Specific Particle Size Distribution
US11013713B2 (en) *	2015-12-15	2021-05-25	Vanda Pharmaceuticals Inc.	Method of treatment
WO2020168056A1 (en) *	2019-02-13	2020-08-20	Vanda Pharmaceuticals Inc.	Method of improving sleep
MX2022006577A (en) *	2019-12-13	2022-07-04	Vanda Pharmaceuticals Inc	LIQUID FORMULATIONS OF TASIMELTEON AND METHODS OF ITS USE.

2007
- 2007-05-22 MX MX2008014841A patent/MX2008014841A/en active IP Right Grant
- 2007-05-22 DK DK07797634.8T patent/DK2028937T4/en active
- 2007-05-22 EP EP07797634.8A patent/EP2028937B2/en active Active
- 2007-05-22 PL PL07797634T patent/PL2028937T5/en unknown
- 2007-05-22 CA CA2666293A patent/CA2666293C/en active Active
- 2007-05-22 CA CA2950087A patent/CA2950087A1/en not_active Abandoned
- 2007-05-22 BR BRPI0712206-3A patent/BRPI0712206A2/en not_active Application Discontinuation
- 2007-05-22 PT PT77976348T patent/PT2028937E/en unknown
- 2007-05-22 ES ES07797634.8T patent/ES2532849T5/en active Active
- 2007-05-22 US US12/301,689 patent/US20090105333A1/en not_active Abandoned
- 2007-05-22 KR KR1020087029431A patent/KR101571163B1/en active Active
- 2007-05-22 AU AU2007253701A patent/AU2007253701A1/en not_active Abandoned
- 2007-05-22 KR KR1020157017784A patent/KR101587394B1/en active Active
- 2007-05-22 RU RU2008150622/15A patent/RU2488392C2/en active
- 2007-05-22 WO PCT/US2007/069411 patent/WO2007137244A1/en not_active Ceased
- 2007-05-22 JP JP2009512250A patent/JP2009538332A/en active Pending
2008
- 2008-11-07 ZA ZA200809529A patent/ZA200809529B/en unknown
2013
- 2013-07-17 AU AU2013207585A patent/AU2013207585B2/en active Active
2014
- 2014-08-21 JP JP2014168550A patent/JP2015013875A/en active Pending
- 2014-11-27 US US14/555,676 patent/US20150080464A1/en not_active Abandoned
2015
- 2015-04-28 CY CY20151100389T patent/CY1120433T1/en unknown
2016
- 2016-02-12 NL NL300795C patent/NL300795I2/nl unknown
- 2016-08-19 US US15/241,178 patent/US20160354337A1/en not_active Abandoned
- 2016-09-20 JP JP2016183125A patent/JP6306114B2/en active Active
2018
- 2018-03-07 JP JP2018040371A patent/JP6480050B2/en active Active
- 2018-04-27 US US15/964,693 patent/US20180243258A1/en not_active Abandoned
2019
- 2019-02-06 JP JP2019019546A patent/JP6659072B2/en active Active
2020
- 2020-09-01 US US17/009,457 patent/US20200397741A1/en not_active Abandoned
2021
- 2021-11-24 AU AU2021273588A patent/AU2021273588B2/en active Active
2022
- 2022-10-14 US US17/655,929 patent/US20230021493A1/en active Pending
2024
- 2024-06-10 US US18/738,235 patent/US20240325339A1/en active Pending

Publication	Publication Date	Title
AU2013207585A1 (en)	2013-08-08	Melatonin agonist treatment
ZA200809529B (en)	2009-12-30	Melatonin agonist treatment
EP1989185B8 (en)	2013-06-26	Therapeutic compounds
WO2007082127A8 (en)	2008-06-12	Combination therapy for long-lasting ckrtm
EP2047792B8 (en)	2019-05-22	Endoscope apparatus
AU2008263581A8 (en)	2010-01-21	Well treatment
GB0624874D0 (en)	2007-01-24	Treatment
GB0600692D0 (en)	2006-02-22	Well treatment
GB0607952D0 (en)	2006-05-31	Novel treatment
GB0604460D0 (en)	2006-04-12	Treatment
AU2012101548A4 (en)	2012-11-22	Water Treatment Apparatus
AU2006905623A0 (en)	2006-10-26	Treatment
AU2007901118A0 (en)	2007-03-22	Treatment methods
AU2006903094A0 (en)	2006-06-22	Diathermy device
HK1133392A (en)	2010-03-26	Combination therapy
AU2006904965A0 (en)	2006-09-28	Apparatus
AU2006903536A0 (en)	2006-07-13	Apparatus
AU2006905320A0 (en)	2006-10-12	Patient Turning Apparatus
AU2006902723A0 (en)	2006-06-08	Therapeutic treatment
AU2007903788A0 (en)	2007-07-26	Biofilm treatment
AU2006902715A0 (en)	2006-06-08	Compounds and Methods
GB0610431D0 (en)	2006-07-05	Treatment
GB0605781D0 (en)	2006-05-03	Treatment
AU2006900405A0 (en)	2006-02-09	Treatment process
AU2006901263A0 (en)	2006-03-30	Portable fishing apparatus